PAUL STRICKLAN D SCANNER CENTRE CANCER IMAGING EXPERTS 2024-2025 Annual port and Financial Statements
----- Start of picture text -----
2
Registered charity no. 298867.
Company no. 2033936
(England and Wales)
----- End of picture text -----
Delightful and ef ficient staff. Very skilled and good at putting people at ease.
PATIENT COMMENT
3
Contents A transcript of this document is available in large print. Please ring 01923 886310.
Chair’s Report Balance Sheet
04 74 Trustees’ Annual Report: Including Cash Flow Directors’ Report Statement 06 75 and Strategic Report Notes to Independent Cash Flow Auditor's Report Statement 70 76 Notes to Statement of Financial Financial Activities
73 77 Statement
----- Start of picture text -----
Balance Sheet
----- End of picture text -----
4
Chair's report
First and foremost, I would like to extend my thanks to all the staff and volunteers at Paul Strickland Scanner Centre. It has been a challenging yet rewarding year, and I am proud of what the team has achieved in an environment of increasing costs where income generation remains difficult.
Research
We have continued to support Mount Vernon Cancer Centre (MVCC) and other NHS Trusts by providing the imaging elements for a range of research projects. In addition, we have provided “open access” to ground-breaking research carried out by Professor Padhani.
Governance and quality
Imaging
PET-CT: Final implementation and optimisation of our new PET-CT scanner, made possible by the generosity of our donors and supporters, was completed this year. Its increased sensitivity, along with the reimagined practices introduced by a new service-management team, has helped the Centre handle the nationwide problem of shortage of radiopharmaceuticals, the radioactive substances used in diagnostic scans of this type.
Patients now require a lower radiation dose for an improved scan quality, and this means that we can stretch the limited supply of radiopharmaceuticals further.
MRI Deep Resolve: Another advance in clinical practice has been the introduction
of machine learning using Siemens Deep Resolve software, which allows us to improve image quality and reduce scan time, enabling a much better patient experience. Key members of the MRI team have shared their learning with other trusts, benefiting more patients around the area.
New MRI services
The team has been working on several new income generation initiatives, and we successfully launched a new whole-body MRI cancer screening service. Led by Prof Anwar Padhani, it is the first self-referral service we have launched for patients in our history; any surplus from the service is being reinvested in patient care. A second self-referral service, a fatty liver assessment MRI, was launched in January 2026.
Sound foundations are necessary to deliver high-quality patient services. The Governance Team has maintained our accreditation with the CQC and UK Accreditation Service, while a focus on security has been delivered by our IT Team in accordance with healthcaresector standards. This solid base helps instil confidence in patients and staff alike.
A commitment to staff development
We understand that patient welfare starts with the staff, and we continued our commitment to supporting and developing staff during this prior year. During this period, staff attended 25 external courses, five industry conferences, and actively progressed in postgraduate education, including three team members completing Postgraduate Diplomas and one completing an MSc. And we are very excited that Paul Strickland Scanner Centre facilitated
C H A I R ' S R E P O R T
5
its first radiographer apprentice. Internal learning was strengthened through seven clinical education sessions and revamped Quality Improvement afternoons. Staff also benefited from bespoke bystander training, new linemanagement development programmes, and recognition at national level, including a poster presentation at the UK Imaging and Oncology Conference.
Fundraising
Fundraising has, of course, played a crucial role in supporting our clinical work throughout our decadeslong history, and our fundraising team has achieved great success this year. Not only were we chosen as charity of the year by both Moor Park Golf Club and Pinner Rotary, and thank you so much for this, but we also raised the highest amounts ever during both our annual spring walk and golf day. In addition, we took major donor engagement to a new level with our Big Give Christmas Challenge 2025 campaign.
However, not everything has been positive this year. We were deeply saddened by the death of our Patron, HRH the Duchess of Kent, in September. The Duchess was a steadfast supporter of our work over the decades and will be fondly remembered by the staff team as a very special person.
It’s all about patients
I am convinced that the steps and achievements outlined above feed into the quality of the patient care that the Centre provides, supporting NHS patients and specifically cancer patients at Mount Vernon Hospital. Our role in supporting the NHS Ten-Year Plan and Cancer Plan is critical to improving the patients’ cancer journey.
Our patients provided 99% positive feedback this year on our contribution to that journey, something that everyone involved can feel proud of.
C H A I R ' S R E P O R T
6
Trustees' Report
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
7
Leading the way in cancer imaging
Our values describe what matters to us at Paul Strickland Scanner Centre. They are a promise of how we will carry out our work – how we will treat our patients, our staff and our partners.
We value the diversity and experience of our community colleagues and partners, creating relationships and climates that provide an opportunity to share, collaborate and grow together.
We create a safe environment where we are curious of the lived experience of others, seek out best practice and are open to listening and hearing new ideas.
We are committed to consistently delivering excellent services and continuously looking to improve through a creative workforce that feels empowered to act in service of our shared purpose.
We provide advanced medical imaging services for the diagnosis, treatment and monitoring of cancer and other clinical conditions.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
8
All the staff were very pleasant and considerate. I felt I was in good hands throughout.
PATIENT COMMENT
9
Beating cancer, one scan at a time
We specialise in medical imaging scans that are critical in the treatment and monitoring of cancer and other serious conditions.
As a registered charity, our focus is on providing the best possible care to improve the lives of our patients. We offer MRI, CT, and PET-CT scans to both NHS and private patients from North West London, Middlesex, Hertfordshire, Buckinghamshire, and Bedfordshire. These scans are essential for diagnosing and monitoring cancer and other serious conditions, such as dementia. We also support life-changing medical
research. As an independent charity with no government funding, we rely on the generosity of our supporters to keep our doors open and help us make a difference in the lives of our patients.
Public benefit
Our board of trustees is focused on making sure the charity’s work meets the Charity Commission’s guidance on public benefit.
This Trustees' Annual Report confirms the purpose, activities and public benefits of the Charity.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
10
Cancer imaging pioneer
Paul Strickland OBE
Dr Strickland qualified in 1943 and came to Mount Vernon Hospital in 1946, becoming a consultant radiotherapist in 1955.
For many years he was Chairman of the Mount Vernon Medical Committee and, in 1970, became head of the Radiotherapy Department. In 1988, 12 years after his official retirement, he was awarded the OBE.
Scanning for opportunities
In the 1970s, two British Nobel Laureates developed the CT and the MRI scanner. Dr Strickland quickly realised the importance of medical imaging in the accurate diagnosis and subsequent treatment of patients with cancer and other serious conditions.
In 1982, in the midst of a recession, he became Vice Chairman of the appeal to obtain a CT scanner for Mount Vernon. A friend remarked: “He was an absolute dynamo. He really drove everybody.” The Appeal was launched in February 1983, aiming to reach £1,250,000 in three years. In just two years, by March 1985, £1,700,000 was raised, enough to fund a CT and an MRI scanner and the building to house them, which became Paul Strickland Scanner Centre. The result is a world-class centre which attracts the highest calibre radiologists and radiographers.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
ii. TAI wool 'Ii11
12
The first diagnostic imaging unit for NHS and private patients in the UK
When Dr Paul Strickland launched his fundraising drive to buy the first scanner for Mount Vernon Cancer Centre, nobody expected that a world-leading, independent cancer imaging centre bearing his name would be thriving on the same spot four decades later. The first diagnostic imaging unit for NHS and private patients in the UK, it opened in 1985 with one CT and one MRI scanner.
The first CT and MRI patients were scanned the same year, and both original scanners underwent the first of many upgrades and replacements in the early 1990s, thanks to the generosity of our supporters.
quicker, meaning we can scan many more patients. Whole-body MRI scanning, which is the centre’s speciality and particularly important for patients with metastatic cancers, would not have been possible back then.
There have been enormous advances in technology over the years. Image quality has improved dramatically, allowing a much more accurate diagnosis, and scans are much
Medical imaging is now an essential part of modern cancer care and changes thousands of lives for the better every year.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
13
Remembering Katherine, The Duchess of Kent
It is with great sadness that we pay tribute to our longstanding Patron, HRH The Duchess of Kent, who died peacefully at Kensington Palace on 4 September 2025, surrounded by her family.
The Duchess served as Patron of Paul Strickland Scanner Centre since the 1980s and officially opened the Centre in 1986. Her support has been a source of strength and pride for everyone connected with our charity. Paul Strickland Scanner Centre CEO Claire Strickland, who has met the Duchess on a
number of occasions, said: “Her unwavering support over four decades has meant a great deal to our staff, patients, and supporters. Her dedication to charitable causes and her empathy for others were evident in her longstanding commitment to our mission of improving our patients’ lives".
The Duchess’s legacy will continue to inspire us as we carry forward the work she so graciously supported.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
14
----- Start of picture text -----
Claire Strickland, CEO
----- End of picture text -----
Our CEO and team
Our staff team is led by Claire Strickland, who has been our Chief Executive since 2014. She reports to our Board of Trustees, which is chaired by Joanne Langfield, a longstanding member of our Board.
We are hugely grateful to a number of very dedicated volunteers who support our charity. Claire is the daughter of our founder and believes that the patient must always come first when delivering high-standard care. Most of our staff are either radiographers (clinical staff who produce CT, MRI and PET-CT images using our specialised equipment) or radiologists (doctors who specialise in diagnosing and reporting on illnesses and injuries through the use of medical images). Other staff support patients by booking appointments and making sure the Centre is efficiently run.
Fundraising and research
Our fundraising and communications team works to raise awareness and money to fund projects, new scanners, research and more. Our clinical staff actively support medical research delivered at the Centre.
A world-class centre which attracts the highest calibre radiologists and radiographers.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
15
Objectives
To provide state-of-the-art cross sectional medical diagnostic imaging systems and operate them principally to benefit patients attending Mount Vernon Cancer Centre, but also for patients referred from anywhere in the UK or abroad. To carry out late translational imaging research.
Our objectives
-
[ To continuously improve the quality of services in order to provide the ] best care and optimise health outcomes for each and every individual.
-
[ To excel at customer service, achieving outstanding levels of communication ] including patient, carer and referrer satisfaction.
-
[ To consolidate services and enhance local access to specialist services in ] order to deliver high-quality, safe, seamless, innovative and integrated services which are sustainable.
-
[ To support the continued development of Paul Strickland Scanner Centre in ] conjunction with Mount Vernon Cancer Centre, and provision of leading local and tertiary cancer services including the development of innovative clinical research.
-
[ To improve staff engagement and organisational culture, ensuring patient safety ] as a top priority.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
16
Objective 1
To continuously improve the quality of services in order to provide the best care and optimise health outcomes for each and every individual.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
17
Staff are brilliant, friendly and caring. PATIENT COMMENT
18
Booking t
First point of contact: our bookings team
Our in-house Patient Bookings Team is often the first port of call for patients. We treat each and every patient as an individual, helping them find them a time slot for their scan that suits them.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
19
UKAS accreditation
We are very proud to continue to have achieved our UKAS Imaging Services Accreditation for the 9th year in a row.
UKAS accreditation of imaging services provides a patientfocused assessment that is designed to give stakeholders, service users, patients and their carers, confidence in their diagnosis and all aspects of their care. UKAS accredits to a recognised standard and this provides a framework for the NHS and private sector to provide consistently high-quality services, delivered by competent staff working in safe environments.
UKAS assesses imaging services to ensure that the standard’s requirements are maintained through regular monitoring. Accreditation to standards is supported by NHS England and recognised by the Care Quality Commission (CQC).
Paula Merry, Quality and Governance Lead at Paul Strickland Scanner Centre, said: “Maintenance of our accreditation with UKAS is a testament to the work every staff member does, providing effective safe service whilst ensuring that the patient remains at the heart of what we do.”
----- Start of picture text -----
Paula Merry, Quality
and Governance Lead
----- End of picture text -----
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
20
Centre recognised in business awards
In January 2025, Paul Strickland Scanner Centre received a Highly Commended award in the Charity/ Social Enterprise of the Year category of the Hillingdon Business Awards.
----- Start of picture text -----
Caption
----- End of picture text -----
The awards recognise outstanding achievements, innovation and commitment to excellence, organising businesses that excel in their sectors and contribute to the borough’s economic and social development.
From left: Andy Shah (Hillingdon Chamber of Commerce CEO), Geraldine Dammen (Paul Strickland Scanner Centre), Philip Corthorne (Mayor of Hillingdon) and Pierre du Bois (Paul Strickland Scanner Centre) at the Hillingdon Business Expo.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
21
Thank you for being so caring, kind and professional.
PATIENT COMMENT
22
Unlocking the secrets of bone health with Deep Resolve software
Our team is using novel imaging techniques to give patients faster, more detailed diagnoses - all in a single scan.
kind of data clinicians need to assess how cancers and other conditions are affecting skeletal structures.
For years, MRI scans have been used to visualise soft tissues with unparalleled clarity. However, when it comes to bones, traditional wisdom has always dictated: “Use a CT scan.” Now, thanks to our pioneering work at Paul Strickland Scanner Centre using Deep Resolve software, that’s beginning to change.
Previously, doctors often relied on MRI to infer what might be happening around the bones but turned to CT scans to understand bone health itself. This meant scheduling additional appointments, creating delays in treatment planning. Our team at Paul Strickland Scanner Centre is changing that paradigm by harnessing the power of Deep Resolve, a deep learning-enhanced imaging technique.
Why Bones Matter in MRI
Bones have always been a challenge for MRI. The imaging relies on hydrogen atoms to generate its stunning visuals, and bone, which is dense and rigid, has very little free hydrogen to offer. As a result, bone structures typically appear black on MRI scans, providing little useful information. Yet, this is precisely the
A new vision with Deep Resolve
Deep Resolve leverages AI to enhance noisy,
low-resolution images into something rich with detail. By refining how MRI captures and processes data, this approach allows radiographers to visualise bone structures alongside the soft tissues in a single scan. According to Will McGuire, a senior radiographer at the Centre, “It’s a novel way of using the MRI scanner in a non-conventional way, addressing one of its major limitations. The results have been groundbreaking.”
Will shares an example of a patient with renal cancer that had metastasised to the bones. Traditional CT imaging showed disrupted bone structures, but with Deep Resolveenhanced MRI, the same abnormalities were clearly visible. This technique not only provides structural details but also integrates maps of cellular density, offering clinicians a comprehensive view of the disease’s impact.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
23
We’re using the MRI scanner in ways it’s not traditionally been thought of, and in doing so, they’re ensuring patients get faster, more detailed diagnoses - all in a single scan.
[WILL MCGUIRE, SENIOR RADIOGRAPHER]
Speeding up the process
or actively destructive can guide critical decisions about therapy.
Efficiency is another triumph of Deep Resolve. While older MRI techniques could take five minutes to scan a single section of the pelvis, newer iterations complete the task in about 30 seconds, a pace rivalling CT scans. “We’re finetuning the balance between scan time and resolution to ensure images are sharp enough for clinical use,” Will explains.
Similarly, clinicians treating breast or kidney cancers now have a tool to assess bone involvement without needing additional scans. While the work is still in its early stages, the potential is immense. Will and his team are taking their findings to the prestigious European Congress of Radiology this year to showcase how this technology could revolutionise imaging worldwide. For our team at Paul Strickland Scanner Centre, this innovation reflects a commitment to pushing boundaries.
A new frontier
This capability isn’t just about convenience; it has real-world implications for treatment. For instance, in prostate cancer, distinguishing whether bone lesions are merely present
----- Start of picture text -----
Will McGuire
----- End of picture text -----
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
24
Striving for the best care and health outcomes for our patients
Our Audit Team actively promotes audit for all Paul Strickland Scanner Centre staff, overseeing development and coordination as well as monitoring implementation of the Centre’s Clinical Audit Programme. The team reports on compliance against existing guidance or internal standards and receives audit proposals as well as audit summary sheets for the Centre. In addition, Audit Team members:
-
[ Receive audit proposals and audit ] summary sheets for the Centre
-
[Receive reports and findings from ] completed audit summaries and approve action plans arising from those audit findings
-
[Develop and maintain a robust system to ] monitor the progress of all Action Plans through to completion
-
[Present findings and learning points to ] Centre staff
-
[Support staff undertaking audit]
-
[Actively promote and search for new ] audit/research ideas.
Advanced Radiographer Manpreet Kaur Punia, our Clinical Audit Lead, joined us from a wellknown private hospital in 2021. She said: “I am incredibly proud of the team’s dedication and resilience this year. Despite increased clinical demands and time constraints, the commitment to maintaining high
standards has been outstanding. A particular highlight was supporting a staff member in successfully taking an audit poster to the UK Imaging and Oncology Congress 2025, showcasing the Centre’s work on a wider stage. This achievement reflects our shared determination to continually improve patient care and we look forward to building on this success in the year ahead.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
25
I am incredibly proud of the team’s dedication and resilience this year.
MANPREET KAUR PUNIA
Advanced Radiographer Manpreet Kaur Punia, our Clinical Audit Lead
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
26
Objective 2
To excel at customer service, achieving outstanding levels of communication including patient, carer and referrer satisfaction.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
27
Arriving
Booking t
Arriving at Paul Strickland Scanner Centre
Patients report for their scan at our reception desk, where they are booked in by a member of our friendly team before waiting for their scan in our waiting room. With input from patients, our waiting room was refurbished thanks to a grant by the National Lottery Community Fund. Pictured Vanessa (left) and Mwai from our reception team.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
28
Patient satisfaction scores
How satisfied were you with the overall experience at Paul Strickland Scanner Centre?
89.6% 9.5% 0.6% Very Satisfied Satisfied Neither
0.6% 0% 0.3% Neither Dissatisfied Very Satisfied nor Dissatisfied Dissatisfied
A total of 454 Paul Strickland Scanner Centre patients took part in our December 2024 patient satisfaction survey.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
29
Patient Experience Group (PEG)
Paul Strickland Scanner Centre has a dedicated multidisciplinary Patient Experience Team, which meets regularly throughout the year and drives the patient experience agenda.
The team is made up of staff members who represent different disciplines within the Centre including radiographers, bookings, administration and communications. In addition to key staff members, patient volunteers are part of the team, ensuring the patient perspective is heard and represented at all times.
agenda by means of an interactive Quality Improvement afternoon.
The team closely tracks the experience of patients at the Centre and the Centre makes changes to the service as a result. One particular success achieved was the introduction of a regular “You Said, We Did” slide show in the Centre’s patient waiting room, showing patients how their feedback makes a difference.
Amongst other projects, multiple methods are used to acquire patient feedback, including via feedback forms handed to patients during the course of their appointment as well as by means of an annual patient satisfaction survey. This data enables us to create and develop a yearly action plan. All members of staff are involved in the patient experience
In addition, Ian Burnell joined the group as a new patient representative. He has been having CT and MRI scans with us for several years and is now sharing his experience to help shape how we care for others. He
Ian Burnell, pictured here with PEG group chair Leah Page.
said: “What really struck me about Paul Strickland Scanner Centre is how friendly the staff are. Everyone smiles. The team is very communicative and approachable, which makes a big difference. I hadn’t realised that Paul Strickland Scanner Centre is an independent charity, and I joined the Patient Experience Group because I was fascinated to learn how the Centre is run. This was particularly interesting to me as someone with experience as a public governor at a large NHS hospital.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
30
The staf f are fantastic
Paul Strickland Scanner Centre patient Rosella shares her experience
“It was my first time visiting Paul Strickland Scanner Centre in October for my yearly MRI, accompanied by my lovely and supportive partner, Mick, who was my chauffeur. We are now making it a yearly 'outing' - MRI and then dinner after! The staff are fantastic; what a wonderful and professional hospital - all concerned made me feel at ease and very looked after.
----- Start of picture text -----
Rosella and her
partner Mick
----- End of picture text -----
Rosella, Paul Strickland Scanner Centre patient
I feel positive, I’m now being looked after and being monitored. The medical pioneer Dr Paul Strickland has essentially given me more years to live, with a high percentage of early diagnosis and without Dr Strickland pioneering and working hard for the Scanner Centre for people like me, I wouldn’t be in this positive position I’m in now.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
31
New self-referral service launched for private patients
For the first time in our history, patients can now self-refer for a whole-body MRI cancer screening scan at Paul Strickland Scanner Centre.
Our new Whole-body MRI Cancer Screening service is a comprehensive and reliable way to check your health and detect any signs of cancer before symptoms appear. The service, which is currently only available privately, is overseen by our lead consultant for MRI Prof Anwar Padhani and is provided on a self-pay basis. Any income generated will help fund our charitable services.
The whole-body MRI scan, which takes around 45 minutes, uses advanced imaging technology to scan the entire body for abnormalities or growths that could indicate cancer. It covers all major organs and tissues, including the brain, liver, kidneys, and bones and is completely non-invasive and painless.
One of our experienced radiologists carefully reviews the results, and a full report is sent to the person’s GP. If anything unusual is found, the GP can arrange further tests or treatment if needed. This scan may appeal to people with a family history of cancer, those with genetic or environmental risk factors, or anyone who wants peace of mind about their health, as detecting cancer early can make a big difference in treatment options and outcomes.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
32
As a parent, my family's well-being starts with my own health. A Whole-Body MRI Cancer Screening Scan at Paul Strickland Scanner Centre gave me peace of mind that potential issues would be detected early, leaving me feeling confident and in charge of my well-being.
CEMILLE, PRIVATE PATIENT.
----- Start of picture text -----
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
----- End of picture text -----
33
Objective 3
To consolidate services and enhance local access to specialist services in order to deliver high-quality, safe, seamless, innovative and integrated services which are sustainable.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
34
Scanning Arriving Booking t
Having a scan at Paul Strickland Scanner Centre
Patients have access to three MRI scanners, a PET-CT scanner as well as a CT scanner at Paul Strickland Scanner Centre. Scan times can vary but we do our utmost to ensure patient comfort and reassurance. We have always prided ourselves on having high-quality and up-to-date imaging equipment, with three of our scanners installed since 2022.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
35
Everything was perfect.
PATIENT COMMENT
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
36
Innovation in PETCT dose optimisation enhances service access
Our collaboration with Mount Vernon Cancer Centre helps us minimise disruption caused by radiopharmaceutical shortages.
PET-CT scans play a vital role in diagnosing and monitoring cancer. However, a nationwide shortage of radiopharmaceuticals - the radioactive substances used in these scans - has posed a serious challenge. Thanks to a new scanner and an innovative collaboration between us and Mount Vernon Cancer Centre, we have been able to keep services running and minimise disruption for patients.
“Radiopharmaceutical supply is now the worst it’s ever been,” says Suzannah Patel, PET-CT Superintendent. “Some weeks, every single day, we face dose disruption - either batch failures or long waits for quality checks.”
The problem stems from our need to use old cyclotrons - particle accelerators for
generating radiopharmaceuticals - which were not built to supply the amount of radioactive tracer required in 2025. They were built over 20 years ago. New generators were due to be commissioned two years ago but were unfortunately delayed. At the same time, scanner upgrades carried out in many hospitals have drastically increased the number of patients being scanned, further adding to the pressure on supplies.
Despite these setbacks, Paul Strickland Scanner Centre has found a way to adapt. A new PET-CT scanner, installed in May 2024 and made possible by the generosity of our donors and supporters, has transformed what’s possible. “It’s significantly more sensitive than our previous scanners,” says
Suzannah. “That means we can inject less radiopharmaceutical and still obtain highquality images. Patients receive a lower radiation dose, and we can stretch our limited supply further.”
Gerry Lowe, Clinical Scientist at Mount Vernon Cancer Centre, explains some of the new scanner’s advantages: “The new scanner uses continuous bed motion, which means we can scan the whole patient smoothly rather than in chunks. It’s faster and produces clearer images. The detector crystals and electronics are also much more advanced, allowing us to optimise both image quality and scan speed.”
This optimisation has led to the development of a new protocol that we call the “low-dose
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
37
alternative scanning technique.” Suzannah says, “If we receive less radiopharmaceutical than expected, we can inject between 50% and 90% of the usual amount and simply scan the patient for longer. It’s not something we do lightly - it has to be approved by a PET consultant radiologist - but it means we can avoid cancelling appointments.”
Gerry adds: “For the same image quality, you can inject less and scan longer. It’s a balancing act, but the new scanner makes it possible.”
The impact on patients is significant. “Since introducing this new protocol, we have managed to reduce the number of appointments being cancelled due to radiopharmaceutical batch failure. This means fewer delays in diagnosis and treatment for more patients.”
The improvements aren’t just technical - they’re clinical too. “The resulting images are much clearer,” says Suzannah. “Radiologists
----- Start of picture text -----
Gerry Lowe,
Clinical Scientist
----- End of picture text -----
love them. Compared to older scanners, the difference is huge. We’re seeing better detection rates and fewer false positives, which is especially important in oncology.”
The Centre’s PET-CT service supports patients with a wide range of cancers, including lymphoma, lung, breast, prostate and colorectal. “We’re also seeing much younger patients being referred,” says Suzannah. “It’s probably a combination of rising incidence and better access to scanning.”
Collaboration has been key to these advances. “Suzannah and I are going to a national meeting in November,” says Gerry. “It’s a tightknit community. We share what we’ve learned and pick up tips from other centres. There’s
PET-CT Superintendent Suzannah Patel (right) with her deputy Bradley Warren
a national shortage of clinical scientists, so if someone’s already optimised a protocol, there’s no point reinventing the wheel.”
Thanks to the dedication of the team and the generosity of supporters, Paul Strickland Scanner Centre is staying ahead of the curve - even in the face of national supply challenges. “If we didn’t have this new scanner,” says Gerry, “we’d be turning away a lot more patients. It’s made a huge difference.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
38
Objective 4
To support the continued development of Paul Strickland Scanner Centre in conjunction with Mount Vernon Cancer Centre, and provision of leading local and tertiary cancer services including the development of innovative clinical research.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
39
----- Start of picture text -----
Scanning
Arriving
Reporting
Booking
Having a scan at
Dr Heminder
Sokhi, a
Paul Strickland
Consultant
Radiologist at
Paul Strickland
Scanner Centre Scanner Centre
Following the appointment, our team of consultant radiologists
will report the scan and send the results to the referring doctor.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
Patien
t
J
o
u
r
n
e
y
----- End of picture text -----
40
23 Peer-reviewed accepted journal publications by our clinical team. Source: PubMed.gov Data refer to the period between 1 October 2024 and 30 September 2025
951 research scans as part of 64 clinical trials (vs 1,017 scans as part of 55 trials during the previous reporting period).
703 involved CT 239 involved MRI scans 9 involved PET-CT scans.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
41
Transforming prostate cancer detection: Fewer harms, earlier answers
Promising research results justify rollout of MRI prostate cancer screening for high-risk men, say experts
Imagine a future where fewer men undergo painful biopsies, fewer are diagnosed with and treated for effectively harmless cancers, and more lives are saved through early detection of aggressive disease. Thanks to strong advocacy involving Paul Strickland Scanner Centre, that future is fast becoming a reality.
Prostate cancer is the most common cancer in men, but screening for it has long been controversial. Traditional tests, like the PSA blood test, can lead to unnecessary biopsies and the detection of slow-
----- Start of picture text -----
Prof. Anwar Padhani,
Lead Consultant for
MRI at Paul Strickland
Scanner Centre
----- End of picture text -----
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
42
growing cancers that may never cause harm. This can result in anxiety, overtreatment, and avoidable side effects.
But now, a powerful new approach is emerging - and Paul Strickland Scanner Centre is at the forefront of it.
Recent international trials, including the Göteborg-2 and Stockholm-3 MRI (STHLM3MRI) studies, have shown that using MRI scans to guide prostate cancer screening is not only safer but also more effective. These studies followed thousands of men over two rounds of screening and found that MRI scans can help doctors focus only on those who truly need a biopsy.
The analysis results are striking. In the first round of screening, MRI scans helped avoid unnecessary biopsies in around 60% of men with raised PSA levels. Even better, the number of aggressive cancers detected went up, while the number of harmless cancers found dropped dramatically. In the second round, the benefits were even greater, with
fewer men needing biopsies and a higher percentage of aggressive cancers being caught.
Prof. Anwar Padhani, Lead Consultant for MRI at Paul Strickland Scanner Centre, recently co-authored the final article in a four-part series on the research published in JAMA Oncology, together with Dr. Ivo Schoots, Radiologist at Erasmus University Medical Centre in Rotterdam.
The research analysis confirms that it’s safe to skip biopsies in men with raised PSA but clear MRI scans, at least for two years.
This is a significant step forward in reducing the physical and emotional toll of prostate cancer screening. The findings are so promising that experts are now calling for the immediate rollout of MRI for men at high risk of cancer, and thereafter, global studies to explore how MRI-based screening could be rolled out at scale. This includes ensuring the technology is accessible, affordable, and consistently used across different healthcare systems.
This research shows that MRI-targeted screening can transform how we detect prostate cancer. It means fewer men go through unnecessary procedures, and more lives can be saved by catching dangerous cancers earlier.”
PROF ANWAR PADHANI
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
----- Start of picture text -----
Dr Amish Lakhani Andrew Gogbashian Dr Anthony Chambers Dr Wai Lup Wong
MBBS MA (Cantab) MB BS MRCS MB BS MRCP FRCR BA (Hons) FRCP
FRCR, Consultant FRCR FRCR
Consultant Oncological
Radiologist Consultant Consultant
and Radionuclide
Lead Consultant, Oncological Radiologist
Training Radiologist, Lead Radiologist,
Consultant for CT Lead Consultant
Professor for PET-CT
Anwar Padhani
MB BS FRCP
FRCR, Consultant
Radiologist Lead
Consultant, MRI
Dr Nemi Gandy Dr Senan Alsanjari Dr Subhadip Dr James Diss Dr Zoltan Kaplar
MBChB FRCR, MBBs, BSc, FRCR Ghosh-Ray BSc (Hons) MBBS MD MPhil
Consultant Consultant BSc MBBS FRCR, PhD FRCR, Consultant
Radionuclide Radiologist Consultant Consultant Radiologist
Radiologist Head and Neck Radiologist
Radiologist
Lead Consultant
for Information
Technology
Dr David Lilburn Dr Kathryn
Dr Heminder Sokhi BSc (Hons) MB ChB Wallitt MBBS, Our
Dr Muhammad MBChB MRCS FRCR, (Hons) MSc PhD FRCR, BSc, FRCR,
Dharas, MBBS BSC Consultant Consultant Radiologist Consultant consultants
Consultant Radiologist (Molecular and Cancer Radiologist,
Radiologist Imaging) Nuclear
Medicine
----- End of picture text -----
44
Fantastic staff. I felt cared for from the moment I arrived.
PATIENT COMMENT
45
Campaigning for patients
We have joined forces with national charities to campaign for a screening programme for men at high risk of developing prostate cancer
----- Start of picture text -----
Ian Burnell, pictured
here with PEG group
chair Leah Page.
----- End of picture text -----
We have joined forces with the charity Prostate Cancer Research and its partners to support the “Proactive for your Prostate” campaign, which calls for a national screening programme to detect prostate cancer earlier— particularly in men at higher risk due to factors like family history or ethnicity.
Prostate cancer is the most common cancer in men, yet the UK still lacks an effective screening programme.
Every 40 minutes, a man dies from the disease, and late diagnosis remains a major problem. Current screening methods are inconsistent, meaning that too many men are either diagnosed too late or undergo unnecessary treatments. The centre is supporting this important campaign
because early detection saves lives. Advanced imaging techniques, like those used at the Centre, can help catch aggressive prostate cancers early while avoiding overdiagnosing harmless cases. However, without a structured national programme, many men, especially those at higher risk, are slipping through the cracks.
The “Proactive for your Prostate” campaign aims to change this by pushing for a fairer, more effective approach to prostate cancer screening.
Prof Anwar Padhani (pictured with former Home Secretary James Cleverly) and Pierre du Bois (with Gary Lineker) were invited to the campaign launch event at the House of Commons in November 2024.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
46
Objective 5 To improve staff engagement and organisational culture, ensuring patient safety as a top priority.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
----- Start of picture text -----
47
Scanning
Arriving Fundraising
Reporting
Booking Patien
t
J
o
u
r
n
e
y
----- End of picture text -----
Giving something back Many of our patients, their families and friends are inspired by our service to “give something back” by fundraising for us.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
48
Fundraising and communications
The centre has a dedicated fundraising and communications team, which works to raise money through our donors and supporters.
In addition to gifts from trusts and foundations and legacies, regular donations and gifts, our regular direct mail appeals to long-standing and new donors, we were fortunate for the fundraising efforts of our runners - and this year even benefitted from the support of “running postie” Louise Rayner! Louise’s fundraising campaign resulted in £2,638 in donations, drew significant local media interest and was featured in the local press as well as BBC Three Counties Breakfast radio.
Fundraising is a challenge in the current economic climate, however the team are proud to have secured a number of successes this year, including being selected as charity of the year by Pinner Rotary and Moor Park Golf Club. Both organisations enthusiastically supported us through donations and fundraising. As a result, our annual charity golf day, held at Moor Park this year, raised more than £25,000, a record amount for the event. Just months earlier, we also raised a £11,500 during our May Bank Holiday Spring Walk, Stepping up for Cancer.
Trying something new is always important, and we were fortunate to exceed the target for our first ever Big Give Christmas Appeal, raising £6,322.
A highlight of this year was the generous support of Mount Vernon Hospital Comforts Fund, who donated more than £23,000 to the centre, funding new phantoms for our PET-CT and MRI departments.
Trying something new is always important, and we were fortunate to Ian Burnell, pictured here with PEG group chair Leah Page. exceed the target for our first ever Big Give Christmas Appeal, raising £6,322.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
Our golf day was held at Moor Park Golf Club in June and raised an amazing £25,000
Our annual Stepping up for Cancer spring walk raised a record £11,500
Supporter Louise Rayner raised thousands for us as a “Running Postie”.
53
Charitable grants
We are grateful to the following charitable trusts and foundations who supported us during the reporting period.
Dudley & Geoffrey Cox Mount Vernon Hospital Charitable Trust Comforts Fund
Big Give Christmas Challenge and The Reed Foundation
Ruislip Round Table
Shanly Foundation
The Hospital Saturday Fund
Oshwal Association of the UK
Westfield Health
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
54
Overall amazing experience despite being a hospital.
PATIENT COMMENT
55
Staf f Attitude Survey: Positive Highlights
Our staff attitude survey was carried out in late 2024 and demonstrates the Centre’s strong commitment to fostering a compassionate, inclusive, and engaging workplace, with several noteworthy highlights:
----- Start of picture text -----
Safety Patient Focus
79% 71% 98% 85% 92%
79% would feel secure raising 98% of staff feel 85% agree that 92% would recommend
concerns about unsafe clinical their role makes a patient care is a top the organisation’s
practice, compared to 71% in the NHS. difference to patients. priority, significantly services to others (as
higher than the NHS opposed to 65% in the
benchmark of 75%. NHS), reflecting a strong
endorsement of the
quality of care provided.
----- End of picture text -----
As a result of the survey, the Centre’s Strategy Team delivered a programme of change in line with our spirit of constant improvement, including a major programme to involve our staff in the development of new values at Paul Strickland Scanner Centre. In addition, our Senior Philanthropy Manager, Geraldine Dammen, carried out an ambitious programme to support and deepen the culture of philanthropy at Paul Strickland scanner Centre.
----- Start of picture text -----
Leadership
74% 78.3%
----- End of picture text -----
74% of our staff said that their immediate line manager works together with them to come to an understanding of problems (as opposed to 67% of NHS staff).
78.3% agreed that their immediate line manager is interested in listening to them when they describe challenges (as opposed to 72.3% in the NHS)
73.3% 72% 73.3%of staff feel 72% said their immediate their manager cares line manager takes effective about their concerns, action to help them with exceeding the NHS any problems they face average of 71%. (vs 67% in the NHS).
Workplace wellbeing
----- Start of picture text -----
81%
----- End of picture text -----
81% of staff said that their immediate line manager takes a positive interest in their health and wellbeing.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
56
Bringing staf f together for shared learning: Our QI afternoons
Members of our clinical team
The Centre holds regular Quality Improvement (QI) afternoons throughout the year, which are an important opportunity for staff engagement and shared learning to ensure an effective and safe working culture.
Topics covered as part of the sessions include:
Results of staff survey and action plan
The Centre carries out an annual staff survey and the results were communicated to all staff during the March QI session.
Patient Experience
The Patient Experience Group gave an update on its achievements over the past months, its updated terms of reference, plans for the year ahead as well as the results of the most recent patient experience survey.
Bystander training
This session taught staff how to safely and effectively intervene in harmful situations, like harassment, discrimination, or potential violence, by moving them from passive witnesses to active participants who can create safer communities.
Safety and audit
Staff were briefed on risk assessments, given an update on fire safety and evacuation protocols as well as the patient safety incident response framework. The audit team updated staff on its programme of work for
the year during an interactive session. Other topics covered include finance, safeguarding, uniforms, PPE and the use of Central Venous Access Devices (CVADs).
Our team let us know that the old uniforms were ready for a refresh — and we agreed it was time to make sure everyone continues to look smart and feel proud in what they wear. The new look reflects the unique professionalism and care our staff at Paul Strickland Scanner Centre bring to every patient, every day.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
57
I feel lucky to be able to come here. PATIENT COMMENT
58
Investing in our team
Investing in our staff is a priority at Paul Strickland Scanner Centre and can make a big difference to patients, as the postgraduate training of Will McGuire and Emma Bycroft, two of our experienced radiographers, shows.
Will McGuire, who joined the Centre in 2013, has completed a Master of Science in Advanced Medical Imaging at the University of Hertfordshire, achieving a distinction. “When I started, I had no formal postgraduate education,” he explains. “This funding allowed me to go from someone with a strong interest in MRI to someone with a deep, evidence-based understanding of how the technology works and how to use it to best serve patients.”
Radiographer Emma Bycroft with her academic achievement award.
Will’s studies didn’t just enhance his technical knowledge. He also gained valuable skills in leadership, communication, and research that are now helping him lead his team more effectively and improve services across the Centre. His final research project focused on optimising prostate MRI scans using cutting-edge deep learning software - technology made possible by previous charitable funding.
“The result is better image quality, even on lower-strength scanners,” he says. “That means more accurate information for oncologists and ultimately better outcomes for patients.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
59
Putting patients first
Emma Bycroft, who has been with the Centre for over a decade, is working towards her Master’s degree at City University in London. She’s already completed a postgraduate diploma, winning an academic achievement award for her top marks in MRI physics and clinical applications.
Her most recent module focused on patient-centred care, and it’s already having a tangible impact. “I chose to focus on autistic patients in MRI,” she says. “We’ve made simple changes - like offering a quiet waiting room, dimmed lights, and one-toone communication - that can make a huge difference to someone’s experience.”
better scans, which leads to better treatment decisions.”
A ripple effect
Both Will and Emma are passionate about sharing what they’ve learned. “The knowledge doesn’t stay with one person,” says Will. “It spreads through the team. Everyone benefits, and so do our patients.” Emma agrees. “I’ve shared all my assignments and presented my work to the department. It’s about raising the standard for everyone.”
Emma’s work is helping ensure that all patients, regardless of their needs, receive compassionate, personalised care. “If a patient is anxious or overwhelmed, they might not even attend their scan,” she explains. “By making small adjustments, we can help them feel safe and supported. That means we get
Why it matters
For patients, the benefits are clear. Bettertrained radiographers mean higher-quality
Mr Will McGuire
scans, more accurate diagnoses, and a more compassionate experience.
For supporters, it’s a powerful reminder of how a legacy gift, no matter the size, can have a lasting impact.
“This funding helps us become not just better radiographers,” says Will, “but more well-rounded professionals. It’s not just about academic achievement, it’s about delivering the best possible care.”
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
60
How we manage principal risks and uncertainties
At bi-monthly board meetings, the Trustees continue to focus on major risks to the charity that would have a severe impact on operational performance as well as reputation, should they occur.
annually. The latest review by the Board took place on 12 September 2025.
The Audit and Risk Committee, which is a subcommittee of the Board of Trustees, met three times during the reporting period. The work of the sub-committee is reported to the Board of Trustees.
We carry out surveys amongst patients and referrers to see how satisfied they are with our service. Our staff analyse the results, develop, and implement action plans to make improvements which will improve the experience for both patients and the doctors who referred them. Clinical audit and peer review of reports form an important part of the overall quality review process and serve not only as a safeguard for patients, but also facilitate individual and collective learning. Reviewing and learning from internal audits, past scan reports and correct identifications
The committee jointly reviews the Centre’s risk register, and during the reporting period reviewed all risks on the register, including compliance, clinical risk, income, contracts, business continuity, costs, investments, succession planning, fundraising, growth, capacity and expansion as well as business approach and governance. The Audit and Risk Committee updates the risk register after each meeting, which the Board then reviews
We carry out surveys amongst patients and referrers to see how satisfied they are with Ian Burnell, pictured our service. here with PEG group chair Leah Page.
of disease or otherwise provides a forum for learning and forms a body of evidence of reflective practice to support annual appraisals and revalidation.
Learning Meetings are held regularly to give radiologists an opportunity to discuss specific cases with learning points. The outcomes of the meeting are communicated to all our reporters by the Radiology Governance Lead. Depending on the urgency of the feedback, prior or subsequent communications between staff and referrers take place through which any potential patient harm is minimised and the lesson learnt is appropriately shared. Through appraisals, reporters also personally reflect on points learned and actions taken. The Centre has a reciprocal peer review arrangement with University College London Hospitals (UCLH) for PET-CT scan reports.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
61
You are all brilliantprofessional, reassuring, friendly and efficient. PATIENT COMMENT
62
Financial review
Financial Summary of 2024/25
This financial review outlines the charity’s financial performance for the year, as detailed in the accompanying financial statements.
Total income for the year ended 30 September 2025 was £10.940m (2024: £9.420m), representing a £1.520m (16%) increase yearon-year. This growth is primarily attributable to the strategic expansion of charitable activities, particularly investment in new PET CT scanners in the prior year.
Income from charitable activities increased to £10.292m (2024: £8.732m), representing an uplift of £1.560m (18%). The principal driver of income continues to be scan volumes. During the year, 21,070 scans were carried out, compared with 20,136 in 2023/24, an increase of 934 scans (5%). This reflects the successful deployment of additional MRI and PET CT scanners. Revenue is also influenced by the type and complexity of scans undertaken, in line with NHS tariff-based pricing structures. Historical scan volumes are summarised below:
2020: 15,116 2021: 16,176 2022: 17,243 2023: 18,823 2024: 20,136 2025: 21,070
Total expenditure increased by £1.410m, rising from £11.479m to £12.889m (12%). The key drivers of this increase were higher staff costs (£617k), increased depreciation (£229k), a rise in medical and surgical supplies expenditure (£296k), and higher heat, light and facilities costs (£159k). In response, the charity has implemented cost management initiatives, including process automation, contract renegotiations, and procurement efficiencies.
The charity reported an overall financial deficit of £1.948m for the year (2024: £2.059m deficit) an improvement of £111k. While this represents a consistent financial performance, it reflects the challenging economic environment, ongoing inflationary pressures, and the constraints of NHS tariff structures, which have not kept pace with the rising cost of delivering services.
Cash at bank was £3.503m at the year end. This represents a reduction of £0.959m from
the closing balance in 2023/24.
Over recent years, the charity has continued to invest significantly in its diagnostic capacity and infrastructure despite a challenging operating environment. In 2022, £1.722m was invested in the installation of two MRI scanners. This was followed in 2023 by £1.446m of preparatory expenditure towards a new PET CT scanner, aimed at expanding capacity and reducing patient waiting times. During 2024, the charity invested £3.818m in property improvements, new scanners, and related equipment.
These investments reflect a deliberate longterm strategy to enhance service delivery, improve patient outcomes, and meet growing demand. While they have contributed to increased depreciation and short-term financial pressures, they position the charity to generate higher activity levels and income in future years.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
63
Financial review
Financial Outlook for 2025/26 Onwards
work includes a review of income streams and diversifying these where possible, strengthening commissioning and funding arrangements, an ongoing review of the Charity’s expenditure, and improving operational efficiencies.
The Charity is operating in a challenging financial environment. As highlighted above, the Charity reported a deficit of £1.948m in 2024/25, with a deficit budget of £1.452m approved for 2025/26. Of the budgeted deficit, approximately £1.15m relates to depreciation, a non-cash accounting charge arising from the Charity’s continued investment in diagnostic capacity and infrastructure.
The Trustees remain confident that the Charity’s continued investment in diagnostic services and infrastructure will strengthen its ability to meet increasing patient demand and support long-term financial sustainability.
The wider economic environment, continued inflationary pressures, and NHS tariff constraints continue to contribute to the financial pressures faced by the Charity. At the same time, demand for diagnostic services continues to increase, requiring ongoing investment in equipment, infrastructure, and workforce capacity.
Going concern basis of accounting
The Trustees have reviewed the use of the going concern basis of accounting in the preparation of the financial statements and have confirmed its use is appropriate. The key considerations in arriving at this conclusion include:
The Trustees remain fully committed to ensuring the long-term financial resilience of the Charity, and its continued delivery of highquality diagnostic services to patients. However, the Trustees recognise that a longer-term strategy is required to ensure the Charity’s financial sustainability. Current
-
[ The PSSC has sufficient resources to ] continue activities for 12 months from the signing of the 2024/25 financial statements, given the level of cash held and its budgeted cash flows;
-
[ Future cancer services on ] the current site remains uncertain, but the Mount Vernon Cancer Centre (MVCC) is recognised as essential to the provision of NHS cancer services in this geographical area; and
-
[ PSSC is recognised by the NHS as a vital ] component in enabling MVCC to provide these services.
Given the above, the Trustees are confident that in the medium to long term the NHS would provide support in order for these vital services to continue, whether under current or new arrangements.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
64
Structure, Governance and Management
Trustees and their interests
Paul Strickland Scanner Centre is a charitable company, limited by guarantee. It is a registered charity governed by its Articles of Association and it does not have share capital, therefore, there are no Trustees’ interests.
Statement of Trustees’ responsibilities
Our Trustees (who are also directors of Paul Strickland Scanner Centre for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and Financial Statements in accordance with applicable laws and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure of the charitable company for that period. In preparing these financial statements, our
Trustees are required to:
-
[ Observe the methods and principles in ] the Charities SORP 2019 (FRS 102);
-
[ Select suitable accounting policies and ] then apply them consistently;
-
[ Make judgements and accounting ] estimates that are reasonable and prudent;
-
[ State whether applicable UK Accounting ] Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
-
[ Prepare the financial statements on a going ] concern basis unless it is inappropriate to presume that the charity will continue its activities.
Our Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable
steps for the prevention and detection of fraud and other irregularities.
How we work
The governing document of Paul Strickland Scanner Centre is its Articles of Association, and policy decisions are made by our Board of Trustees. As set out in the Articles of Association, new Trustees may be appointed by the existing Trustees by resolution but must retire from office at the next general meeting and shall be eligible for election at that meeting. At each annual general meeting one third of the Trustees must retire from office. The Trustees to retire by rotation shall be those who have been longest in office since their last appointment. A Trustee shall not hold office for more than nine consecutive years and shall not be eligible for appointment or re-election upon the expiry of such period until a period of 12 months has elapsed since they retired as a Trustee. There shall be a minimum of three and a maximum of 12 Trustees. Our Trustees come from a variety of backgrounds and have been carefully chosen
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
65
because of their qualifications, experience, or connections to our cause and patient community.
Our Chief Executive Officer is Claire Strickland. She isn’t on the board and the Trustees have delegated the daily running of the charity to her and she is supported by the staff team. Claire and her strategy team are accountable to the Board of Trustees, who meet six times per year.
New Trustees
When we need a new Trustee to join our Board, we invite candidates to the Centre, show them around and tell them about our work. Candidates are selected by interview involving at least two Trustees. They also meet the other Trustees and get the opportunity to ask them about the charity and the work of the Board. We circulate their CV to the existing Trustees and provide the candidate with an information pack about the different types of scans at the Centre, our financial situation and the latest financial statements. Once their appointment has been agreed by the board, we provide new Trustees with copies of our governing documents. This includes the Board's Terms of Reference, statement of Trustee liability, frequency and timings of board meetings, a list of current Trustees, organisational structure, our current strategic plan and summary of all insurance
policies. Each Trustee takes part in a carefullydesigned induction programme to help them understand how we help patients and their families as well as what their responsibilities are.
Investment powers
Under the Articles of Association, our Trustees have the power to decide which investments are best for the charity. We follow a cautious investment strategy and have taken careful steps to make sure that our reserves are not put at undue risk. During the period and at the Balance Sheet date, most of our cash reserves have been put in short term fixed deposit accounts spread across a range of institutions. This is a prudent approach and deposits are held in short term account of usually no longer than 6 months maturity so that we remain flexible.
Reserves policy statement
The Charity diligently establishes, and regularly evaluates, its reserves policy to safeguard the maintenance of sufficient funds that cover essential operational expenses, including staff salaries and associated costs. The aim of the Charity is to hold unrestricted funds to cover operational expenses for a six to nine months period.
This is to ensure that not only will ongoing commitments be fulfilled, but also to sustain services in alignment with the Charity’s
objectives. Our reserves policy has been developed taking account of guidance published by the Charity Commission. This strategic approach is designed to facilitate responsiveness during emergencies, safeguard the well-being of our patients, and provide the flexibility to redirect resources for intricate and enduring specialist clinical care pathways, should the unlikely event of winding up the Charity arise. The Trustees are aware of the finite operational lifespan of the scanning equipment currently in use. Consequently, provisions are set aside from the accumulated fund to acknowledge the Charity’s future commitment to funding the vital replacement of older equipment. By aiming to adhere to these financial practices, we will assure potential funding partners that our commitment to financial prudence is aligned with sustaining our mission and responsibilities as a provider of state-of-theart imaging scans.
The Charity’s 2024/25 financial statements show that the total free reserves amounted to £2.088m (2024: £2.597m). This represents the portion of the Charity’s funds not designated for specific purposes.
Total operating expenses for the 2024/25 financial year were £12.602m (2024: £11.207m), meaning coverage is only currently possible for circa two months of
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
66
expenditure. Therefore the Charity was unable to adhere to its reserves policy in 2024/25, given that the level of unrestricted reserves was below the target range. This position reflected:
-
[ Significant capital investments in PET-CT ] and MRI scanners made during recent years; and
-
[ Recent and forecast operational deficits ] resulting from the economic downturn, inflationary pressures, and NHS tariff constraints, which limit income despite rising service delivery costs.
Despite this, the charity maintains in a reasonable liquidity position, with total cash and investment balances of £3.503m (2024: £4.462m) representing a reduction of £0.959m in-year. The Trustees have assessed the current financial situation and concluded that a temporary reduction in the reserves target to 3 months of operational expenditure is appropriate and realistic in the short to medium term.
The Trustees are closely monitoring this position. While current reserves are deemed sufficient to meet the charity’s immediate operational needs, continued operational deficits are forecast. The budgeted deficit for the 2025/26 financial year is £1.452m.
The Trustees recognise that a longer-term strategy is required to restore reserves to the desired range.
Strategies under active consideration include:
-
[ Diversifying income streams]
-
[ Strengthening commissioning and funding ] arrangements
-
[ Improving operational efficiencies]
The Trustees remain fully committed to regularly reviewing the Reserves Policy and the financial position of the charity to ensure long-term resilience and the continued delivery of high-quality diagnostic services to patients.
Staff pay and conditions
Pay and conditions of staff are determined nationally, as set out in the NHS Terms and Conditions of Service Handbook and subject to a national job evaluation scheme.
Criteria and measures used to assess success in the reporting period
A set of key performance indicators is in place and these are measured throughout the reporting period, so that Trustees can assess the charity’s performance and results against its objectives to ensure the charity is working towards meeting them. It is reviewed and discussed at board meetings. The measures
include activity, quality, patient experience and contract compliance and these are discussed in the relevant earlier sections of the report.
Fundraising compliance
The fundraising team at Paul Strickland Scanner Centre organises events and other fundraising activities in the local community. The high cost of living brought about by elevated energy and food prices as well as much higher mortgage rates due to a significant rise in interest rates in recent years has put pressure on our fundraising income streams in common with many other charities, as donors have less disposable income than previously. The team has taken mitigating actions as a result, including focusing on major donor and trusts and foundations fundraising capacity, plus continuing our sustained focus on legacies fundraising. Delivering value for money to our donors is important to us and in December 2024 we took part in The Big Give Christmas Challenge matchfunding campaign for the first time and successfully went over our fundraising target. Additionally, we have reached out to community groups and the local business community to raise our profile and establish new fundraising income streams.
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
67
Paul Strickland Scanner Centre has signed up to the Fundraising Regulator’s Code of Fundraising Practice. The team keeps up to date with the latest developments and best practice by attending conferences and webinars throughout the year. Volunteer fundraisers are given a briefing by the Information Governance lead before they raise funds for Paul Strickland Scanner Centre.
All direct marketing is undertaken by the fundraising team and trained volunteers to ensure that it is not unreasonably intrusive or persistent. Contact is made through direct marketing five times a year with our supporter magazine, as well as through relevant emails to those who have consented to receiving email and selective leaflet drops in the community. We closely follow UK-GDPR guidelines. All marketing material contains clear instructions on how a person can be removed from mailing lists. No complaints for conduct that contravenes the Fundraising Regulator’s Code of Practice were received by the department in this period.
Board of Trustees
The Trustees serving during the year and since year end were as follows:
Mrs Nimisha Jadeja Ms Joanne Langfield (Chair) Mrs Jean Liao Mr David Maloney (Treasurer - appointed 28 June 2025) Mr André Nunes Ms Amy Page Ms Victoria Poole (resigned 30 June 2025) Mr Daniel Ross (Treasurer – resigned 31 December 2025 ) Mr George Wharton Dr Terence Wright (appointed 27 May 2025)
T R U S T E E S ’ A N N U A L R E P O R T : I N C L U D I N G D I R E C T O R S ’ R E P O R T A N D S T R A T E G I C R E P O R T
Other administrative details
Company Number: 02033936 Charity registration number: 298867
Registered office: Paul Strickland Scanner Centre, Mount Vernon Hospital, Rickmansworth Road, Northwood, HA6 2RN Principal Bankers: Barclays Bank plc. Solicitors: Veale Wasbrough Vizards LLP
Auditors
Our auditors, Nunn Hayward LLP, are deemed to be reappointed under section 487(2) of the Companies Act 2006. Their address is: Nunn Hayward LLP, Chartered Accountants and Statutory Auditor, 2-4 Packhorse Road, Gerrards Cross, Buckinghamshire, SL9 7QE.
RELATED PARTIES
Details of transactions with Trustees and other related parties are given in Note 17 to the financial statements.
STATEMENT OF DISCLOSURE TO THE AUDITORS
So far as the Trustees are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the charity’s auditors are unaware, and each Trustee has taken all the steps that they ought to have taken as Trustees in order to make themselves aware of any relevant audit information and to establish that the charity’s auditors are aware of that information. In approving the Trustees’ Annual Report, we also approve the strategic report included therein, in our capacity as company directors.
Ms Joanne Langfield,
Chair of the board of Trustees, dated Tuesday 23rd June 2026 On behalf of the Board of Trustees
69
Always great service, friendly staf f. PATIENT COMMENT
70
Independent Auditor's Report
TO THE MEMBERS OF PAUL STRICKLAND SCANNER CENTRE
Opinion
- [ have been properly prepared in accordance ] with United Kingdom Generally Accepted Accounting Practice; and
We have audited the financial statements of Paul Strickland Scanner Centre (the 'charitable company') for the year ended 30 September 2025 which comprise the statement of financial activities, the balance sheet, cash flow statement and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
- [ have been prepared in accordance with the ] requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
In our opinion the financial statements:
- [ give a true and fair view of the state of ] the charitable company's affairs as at 30 September 2025 and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.
Other information
The trustees are responsible for the other information. The other information comprises the information included in the trustees' annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider
I N D E P E N D E N T A U D I T O R ' S R E P O R T
71
whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
[ the information given in the trustees' ] report, which includes the strategic report and the directors’ report prepared for the purposes of company law, for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
[ the strategic report and the directors’ ] report included within the trustees' report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the charitable company and its environment obtained in the course
of the audit, we have not identified material misstatements in the strategic report and the directors' report included within the trustees' report.
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you, if in our opinion:
-
[ adequate accounting records have not ] been kept or returns adequate for our audit have not been received from branches not visited by us or;
-
[ the financial statements are not in ] agreement with the accounting records and returns or;
-
[ certain disclosures of trustees' and ] directors' remuneration specified by law are not made or;
-
[ we have not received all the information ] and explanations we require for our audit.
Responsibilities of Trustees
As explained more fully in the Statement of Trustees Responsibilities set out on page 64, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.
Auditor's Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We identified and assessed the risks of material misstatement of the financial statements from irregularities, whether due to fraud or error, then designed and performed audit
I N D E P E N D E N T A U D I T O R ' S R E P O R T
72
procedures that addressed these risks in order to obtain sufficient and appropriate audit evidence to provide a basis for our opinion. These procedures and the extent to which they are capable of detecting irregularities, including fraud, are detailed below.
-
[ Enquiry of management, those charged ] with governance and the charitable company’s solicitors around actual and potential litigation and claims.
-
[ Enquiry of the charitable company’s staff in ] accounting, tax and compliance functions to identify any instances of non-compliance with laws and regulations having a direct effect on the financial statements including the Companies Act 2006, the Charities Act 2011 and the Charities SORP (FRS 102).
-
[ Reviewing financial statement disclosures ] and testing to supporting documentation to assess compliance with the above mentioned laws and regulations,
-
[ Enquiry of the charitable company’s ] staff in accounting, tax and compliance functions to identify any instances of noncompliance with other laws and regulations which do not have a direct effect on the financial statements but compliance with which could be fundamental to the charity's ability to operate or to avoid a material penalty, including CQC regulations.
-
[ Reviewing minutes of meetings of those ] charged with governance including their own assessment of significant risks as
-
carried out and reported by the Audit and Risk Committee
-
[ Auditing the risk of management override ] of controls, including through testing journal entries and other adjustments for appropriateness, and evaluating the business rationale of significant transactions outside the normal course of business.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
This report is made solely to the charitable company's members (who are also the
trustees for the purposes of charity law and the company's members and directors for the purposes of company law), as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006, and to the charity’s trustees, as a body, in accordance with regulations made under section 154 of the Charities Act 2011. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Tom Lacey (Senior Statutory Auditor)
for and on behalf of Nunn Hayward LLP, Statutory Auditor
Nunn Hayward LLP is eligible to act as an auditor in terms of Section 1212 of the Companies Act 2006
2-4 Packhorse Road, Gerrards Cross, Buckinghamshire SL9 7QE
Date: Tuesday 23rd June 2026
I N D E P E N D E N T A U D I T O R ' S R E P O R T
73
Statement of financial activities (including income and expenditure account)
FOR THE YEAR ENDED 30TH SEPTEMBER 2025
| General Fund £ 337,323 10,291,557 233,820 |
Designated Fund £ - - - |
Restricted Fund £ 77,674 - - |
Total 2025 £ 414,997 10,291,557 233,820 |
Total 2024 £ 358,294 8,731,638 329,888 |
|---|---|---|---|---|
| 10,862,700 | - | 77,674 | 10,940,374 | 9,419,820 |
| - - |
- 8,556 |
286,130 12,602,393 |
272,411 11,206,553 |
|
| 286,130 12,593,837 |
||||
| 12,879,967 | - | 8,556 | 12,888,523 | 11,478,964 |
| (2,017,267) 1,508,012 |
- (1,489,256) |
69,118 (18,756) |
(1,948,149) - |
(2,059,144) - |
| (509,255) 2,597,162 |
(1,489,256) 7,043,206 |
50,362 75,278 |
(1,948,149) 9,715,646 |
(2,059,144) 11,774,790 |
| 2,087,907 5,553,950 125,640 7,767,497 9,715,646 |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
The notes on pages 76 to 89 form part of these financial statements.
F I N A N C I A L S T A T E M E N T S
74
Balance sheet
BALANCE SHEET AS AT 30TH SEPTEMBER 2025
| Notes FIXED ASSETS Tangible assets 8 Investments 9 CURRENT ASSETS Debtors 10 Cash at bank and in hand 9 CREDITORS - AMOUNTS FALLING DUE WITHIN ONE YEAR Creditors and accruals 11 NET CURRENT ASSETS TOTAL ASSETS LESS CURRENT LIABILITIES CREDITORS - AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR 12 TOTAL NET ASSETS FUNDS: Unrestricted funds: - General funds 16 - Designated funds 16 Total unrestricted funds Restricted funds 16 TOTAL CHARITY FUNDS |
2025 £ 2,989,285 3,503,206 |
£ 5,553,950 - |
2024 £ 2,158,448 4,230,773 |
£ 6,812,206 231,000 |
|---|---|---|---|---|
| 5,553,950 2,213,547 |
7,043,206 2,689,415 |
|||
| 6,492,491 4,278,944 |
6,389,221 3,699,806 |
|||
| 7,767,497 - |
9,732,621 16,975 |
|||
| 7,767,497 | 9,715,646 | |||
| 2,087,907 5,553,950 |
2,597,162 7,043,206 |
|||
| 7,641,857 125,640 |
9,640,368 75,278 |
|||
| 7,767,497 | 9,715,646 |
These financial statements were approved by the Trustees on Tuesday 23rd June 2026.
Mr David Maloney - Trustee
Ms Joanne Langfield – Trustee
Company number: 02033936 Registered Charity number: 298867
The notes on pages 76 to 89 form part of these financial statements.
F I N A N C I A L S T A T E M E N T S
75
Cash flow statement
FOR THE YEAR ENDED 30TH SEPTEMBER 2025
| 2025 | 2024 | ||
|---|---|---|---|
| Notes | £ | £ | |
| CASHFLOWS FROM OPERATING ACTIVITIES | |||
| Net cash used in operating activities | 1 | (925,873) | (425,475) |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Interest received on deposits held | 88,824 | 136,002 | |
| Purchase of tangible fxed assets | (98,168) | (3,818,170) | |
| Net cash used in investing activities | (9,344) | (3,682,168) | |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Interest paid | (1,441) | (2,495) | |
| Repayment of obligations under fnance leases | (21,909) | (20,854) | |
| Net cash used in fnancing activities | (23,350) | (23,349) | |
| (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS | (958,567) | (4,130,992) | |
| CASH AND CASH EQUIVALENTS | |||
| AT THE BEGINNING OF THE YEAR | 4,461,773 | 8,592,765 | |
| CASH AND CASH EQUIVALENTS | |||
| AT THE END OF THE YEAR | 2 | 3,503,206 | 4,461,773 |
F I N A N C I A L S T A T E M E N T S
76
Notes to the cash flow statement
FOR THE YEAR ENDED 30TH SEPTEMBER 2025
1. RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW FROM OPERATING ACTIVITIES
| Net expenditure and net movement in funds for the year (as per the Statement of Financial Activities) Adjustments for: Depreciation charges Interest received Interest paid (Increase)/decrease in debtors Increase/(decrease) in creditors Net cash used in operating activities 2. ANALYSIS OF CASH AND CASH EQUIVALENTS Fixed asset investments - term deposits Cash at bank and in hand |
2025 2024 £ £ (1,948,149) (2,059,144) 1,356,424 1,127,203 (88,824) (136,002) 1,441 2,495 (830,837) 124,314 584,072 515,659 |
|---|---|
| (925,873) (425,475) |
|
| 2025 2024 £ £ - 231,000 3,503,206 4,230,773 |
|
| 3,503,206 4,461,773 |
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
77
Notes to the financial statements
FOR THE YEAR ENDED 30TH SEPTEMBER 2025
1. STATUTORY INFORMATION
Paul Strickland Scanner Centre is a company limited by guarantee registered in England and Wales (company number 02033936). The liability of the members (who are also the trustees) is limited to £1 each in the event of winding up. The charity's registered and principal office is Mount Vernon Hospital, Northwood, Middlesex, HA6 2RN.
The accounts are presented in £ Sterling and rounded to the nearest £1.
2. STATEMENT OF ACCOUNTING POLICIES
The accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:
2.1 Basis of preparation
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Accounting Practice.
Paul Strickland Scanner Centre meets the definition of a public benefit entity under FRS 102. The financial statements are prepared on a going concern basis and under the historic cost convention unless otherwise stated in the relevant accounting policy note(s).
arising from legacies, donations and gifts, all income is credited to the statement of financial activities on a receivable basis.
Income from donations and gifts is recognised on a cash received basis. Income from pecuniary legacies are recognised as receivable once probate has been granted and notification has been received. Residuary legacies are recognised as receivable once probate has been granted, provided that sufficient information has been received to enable valuation of the charity's entitlement.
Income tax recoverable in respect of gift aid donations received to 30 September 2025 has been accrued for in these financial statements.
Fees receivable for scans are brought into the financial statements on the date on which the services are provided by the scanner centre.
Investment income is recognised on a receivable basis
Grants received, which relate to a specific period of time, are dealt with on an accruals basis.
2.3 Donated services
The charity is not in receipt of any donated goods or services except for general volunteers and advertising services. In accordance with the Charities SORP (FRS 102), the economic contribution of general volunteers is not recognised in the accounts. Advertising services are recognised as income donated in the period in which the service is received,with an equal amount recognised as an expense in the same period.
2.2 Income
Income is credited to the statement of the financial activities in the period to which it relates. With the exception of voluntary income
2.4 Expenditure
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is reported as part of the expenditure to which it relates.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
78
Costs of raising funds comprises the costs associated with attracting and managing donated income.
Expenditure on charitable activities comprises services identifiable as wholly or mainly in support of the company's charitable and operational work. These costs are regarded as an integral part of carrying out the direct charitable objectives of the charity and include an appropriate proportion of overhead costs. Research and development expenditure is written off in the statement of financial activities in the year in which it is incurred.
Governance costs comprise expenditure incurred for constitutional and statutory requirements and are included within expenditure on charitable activities.
Support costs are costs indirectly incurred by the charity in supporting its charitable activities. They include the central functions and have been allocated to categories on a basis consistent with the use of resources.
2.5 Tangible fixed assets
Tangible fixed assets are stated at cost less accumulated depreciation and any impairment losses. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
Land and buildings leasehold - over the length of the lease Property improvements - over the length of the lease Scanners - between 5 - 7 years straight line Scanner upgrades - between 4 - 6 years straight line Equipment - 25% straight line
Where significant building costs are incurred in order to install the new scanners, these costs are capitalised and depreciated in line with the respective scanner. General property improvements are depreciated over the remaining length of the lease.
At the year end fixed assets are reviewed to determine whether there is any indication that those assets have suffered impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected assets is estimated and compared to its carrying amount. If the estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised in the statement of financial activities.
If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the assets in prior years. A reversal of an impairment loss is recognised immediately in the statement of financial activities.
2.6 Investments
Investments are deposits held at bank which have been set aside for future capital expenditure and equal the amount in the designated fund.
2.7 Debtors
Fees receivable and other debtors are recognised at the settlement amount due. Prepayments are valued at the amount prepaid based on the cost value of the expenditure suffered.
2.8 Cash at bank
Cash at bank includes cash held in current, deposit and treasury deposit accounts and excludes amounts recognised under investments.
2.9 Creditors and provisions
Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or reliably estimated. Creditors and provisions are normally recognised at their settlement amount.
2.10 Finance and operating leases
Leases are classified as finance leases whenever the terms of the lease
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
79
transfer substantially all the risks and rewards of ownership of the leased asset to the charity. All other leases are classified as operating leases.
Assets held under finance leases are recognised initially at fair value of the leased asset at the inception of the lease. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation. Lease payments are apportioned between finance charges and a reduction of the lease obligation using the effective interest method so as to achieve a constant rate of interest on the remaining balance of the liability. Finance charges are recognised in the statement of financial activities. Assets held under finance leases are included in tangible fixed assets and depreciated and assessed for impairment in the same way as owned assets.
Rentals payable under operating leases are charged on a straightline basis over the term of the lease. The aggregate benefit of lease incentives are recognised as a reduction to the expense recognised over the lease term on a straight line basis.
2.11 Taxation
2.13 Financial instruments
The charity only has financial assets and liabilities of a kind that qualify as basic financial instruments: cash at bank, debtors and creditors. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.
2.14 Judgements and estimation
Preparation of the financial statements requires management to make significant judgements and estimates. The items in the financial statements where judgements and estimates have been made include:
Useful economic life of tangible assets
The annual depreciation charges for tangible assets are sensitive to changes in the estimated useful economic lives and residual values of the assets. The useful economic lives and residual values are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and physical condition of the assets.
The company is a registered charity and, therefore, is not liable for income tax or corporation tax on income derived from its charitable activities, as it falls within the various exemptions available to registered charities if applied for charitable purposes.
2.12 Funds
Unrestricted funds (general funds and designated funds) are those funds expendable at the discretion of the trustees in accordance with the charitable objects.
Restricted funds are monies raised for, and their use restricted to, a specific purpose, or donations subject to donor imposed conditions.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
80
3. INCOME
| 3. INCOME | |
|---|---|
| Donations and legacies Donations, gifts and funds raised Trusts and Grants Legacies Gift Aid recoverable on donations |
2025 2024 £ £ 235,555 201,150 57,005 10,980 100,989 127,369 21,448 18,795 |
| 414,997 358,294 |
Donations, gifts and funds raised comprises donated services totalling £13,778 (2024: £34,903) for advertising services.
| Income from charitable activities Fees from patients and health authorities Investment income Royalties receivable Cyclotron rental income Bank interest and bank treasury deposit interest receivable |
2025 2024 £ £ |
|---|---|
| 10,291,557 8,731,638 |
|
| 2025 2024 £ £ - 48,874 144,996 145,012 88,824 136,002 |
|
| 233,820 329,888 |
4. NET INCOME
| 4. NET INCOME | ||
|---|---|---|
| 2025 | 2024 | |
| £ | £ | |
| Net income is stated after charging: | ||
| Operating lease rentals | 1,790,742 | 1,603,816 |
| Finance lease interest | 1,441 | 2,495 |
| Auditors’ remuneration - audit | 18,500 | 17,000 |
| Auditors’ remuneration - | 12,741 | 3,000 |
| accountancy services | ||
| Depreciation | 1,356,424 | 1,127,203 |
5. COSTS OF RAISING FUNDS
| Fundraisers’ salaries and assistance Advertising Event costs Printing and mailing General expenses |
2025 2024 £ £ 223,351 193,376 13,778 34,903 19,060 16,700 22,663 19,153 7,278 8,279 |
|---|---|
| 286,130 272,411 |
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
81
6. ANALYSIS OF TOTAL RESOURCES EXPENDED
| 2025 Costs of generating funds: Fundraising and related activities Charitable activities: Clinical services 2024 - Comparative information Costs of generating funds: Fundraising and related activities Charitable activities: Clinical services SUPPORT COSTS 2025 Clinical services 2024 - Comparative information Clinical services |
Direct Costs £ 286,130 |
Support Costs Governance Costs Total £ £ £ - - 286,130 |
|---|---|---|
| 10,880,092 | 1,689,060 33,241 12,602,393 |
|
| 11,166,222 | 1,689,060 33,241 12,888,523 |
|
| 272,411 | - - 272,411 |
|
| 9,716,888 | 1,467,665 22,000 11,206,553 |
|
| 9,989,299 | 1,467,665 22,000 11,478,964 |
|
| Staffng Costs Other Costs Total £ £ £ 757,729 931,331 1,689,060 |
||
| 626,160 841,505 1,467,665 |
Support costs represent the staffing costs which are not directly attributable to the clinical services of the charity and other costs including insurances, building costs and general office expenditure which are again, not directly attributable to clinical services. No allocation of support costs has been made to either the research or fundraising functions of the charity as these are deemed to be negligible.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
82
7. ANALYSIS OF TOTAL STAFFING COSTS
The East and North Hertfordshire NHS Trust employs staff under joint contracts with the charity. The Trust administers the payroll and the charity is recharged for its share of the associated costs. These recharges are detailed below:
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Wages and salaries | 3,492,054 | 3,106,153 | |
| Social security | 427,731 | 335,720 | |
| Pension | 827,617 | 688,013 | |
| 4,747,402 | 4,129,886 | ||
| During the year, emoluments of recharged staff earning in excess of £60,000 was as follows: | |||
| 2025 | 2024 | ||
| No. | No. | ||
| £60,000 to £70,000 | 8 | 2 | |
| £70,000 to £80,000 | 2 | 1 | |
| £80,000 to £90,000 | 0 | 1 | |
| £90,000 to £100,000 | 0 | 2 | |
| £100,000 to £110,000 | 1 | 1 | |
| £110,000 to £120,000 | 2 | 0 | |
| £130,000 to £140,000 | 1 | 1 | |
| £150,000 to £160,000 | 1 | 0 |
Key management comprise the trustees and the leadership team. Remuneration of key management in the year was £1,954,360 (2024: £1,745,840).
Total donations to Paul Strickland Scanner Centre made by the trustees in the year amounted to £197. The cost of trustees' indemnity insurance borne by the charity was £1,901 (2024: £2,221).
The trustees did not receive any remuneration or fees for their services to the charity during the year under review.
The number of recharged staff earning above £60,000 to whom retirement benefits are accruing under defined benefit schemes was 15 (2024: 8).
The average number of staff analysed by function was as follows:
| Medical and radiographic Clerical and administration |
2025 2024 No. No. 63 64 12 10 |
|---|---|
| 75 74 |
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
83
8. TANGIBLE FIXED ASSETS
| Cost At 1 October 2024 Additions Disposals At 30 September 2025 Depreciation At 1 October 2024 Charge for the year Disposals At 30 September 2025 Net book value At 30 September 2025 At 30 September 2024 |
Leasehold Land & Buildings Property Improvements Scanners Equipment Total £ £ £ £ £ 2,091,883 4,604,898 6,139,072 2,851,642 15,687,495 - 44,380 - 53,788 98,168 - (671,532) - - (671,532) |
|---|---|
| 2,091,883 3,977,746 6,139,072 2,905,430 15,114,131 |
|
| 2,091,883 1,246,534 3,028,589 2,508,283 8,875,289 - 529,774 630,630 196,020 1,356,424 - (671,532) - - (671,532) |
|
| 2,091,883 1,104,776 3,659,219 2,704,303 9,560,181 |
|
| - 2,872,970 2,479,853 201,127 5,553,950 |
|
| - 3,358,364 3,110,483 343,359 6,812,206 |
Included above are assets held under finance leases as follows:
| Net book values At 30 September 2025 At 30 September 2024 Depreciation charge for the year At 30 September 2025 At 30 September 2024 Included above are assets held un |
un | er fnance leases | a | follows: | Equipment £ - |
||||
|---|---|---|---|---|---|---|---|---|---|
| 23,854 | |||||||||
| 23,854 | |||||||||
| 26,022 | |||||||||
The expenditure on land buildings as shown above does not include the cost of the main building housing the Scanner Centre. Had these costs been capitalised then they would have been fully depreciated by 30 September 2005.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
84
9. CASH AND CASH EQUIVALENTS
| 9. CASH AND CASH EQUIVALENTS | ||
|---|---|---|
| 2025 | 2024 | |
| £ | £ | |
| Investments - cash at bank and on deposit | - | 231,000 |
| Cash at bank and in hand | 3,503,206 | 4,230,773 |
| Cash and cash equivalents | 3,503,206 | 4,461,773 |
Amounts included in investments represent cash at bank and other cash investments set aside by the charity as planned capital expenditure over the next three financial years. As such, capital preservation of these funds is deemed to be of paramount importance and in order to minimise risk, the charity has decided that these funds should be held in cash deposits which are geared to mature in line with the planned capital expenditure schedule.
10. DEBTORS
| Fees receivable Prepaid scanner maintenance costs Other debtors Prepayments Legacies receivable |
2025 2024 £ £ 2,203,353 1,393,596 278,786 233,226 290,290 255,371 139,551 181,251 77,305 95,004 |
|---|---|
| 2,989,285 2,158,448 |
Included in fees receivable is £583,814 (2024: £369,153) due from East and North Hertfordshire NHS Trust.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
85
11. CREDITORS - AMOUNTS FALLING DUE WITHIN ONE YEAR
| Trade creditors Accruals and deferred income Other creditors - East and North Hertfordshire NHS Trust Other creditors Value added Tax Net obligations under fnance leases 12. CREDITORS - AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR Net obligations under fnance leases Amounts payable: Over one year but less than fve |
2025 2024 £ £ 1,656,394 2,232,206 1,143,918 637,271 1,222,890 762,882 231,336 43,359 7,250 1,998 17,156 22,090 |
|---|---|
| 4,278,944 3,699,806 |
|
| 2025 2024 £ £ - 16,975 |
|
| - 16,975 |
Net obligations under finance leases are secured on the assets concerned.
13. FINANCIAL COMMITMENTS
At 30 September 2025 the charity was committed to making the following payments under non-cancellable contracts over the life of the lease:
| Operating and service contracts which expire: Less than one year Over one year but less than fve Over fve years |
2025 2024 £ £ 483,248 401,073 1,011,964 1,096,152 233,968 317,120 |
|---|---|
| 1,729,180 1,814,345 |
Financial commitments on scanner maintenance agreements will lapse when the related scanner is replaced. The financial commitments on such agreements are recognised over the estimated remaining life of the scanners.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
86
14. CAPITAL COMMITMENTS
The Trustees regularly review the need to upgrade or replace assets in order to maintain operational efficiency and offer up to date medical imaging to patients. As at the year end, the charity's capital expenditure planned for 2025/26 is £Nil.
15. ANALYSIS OF NET ASSETS BETWEEN FUNDS
| Fixed assets Current assets Creditors due within one year Creditors due after one year Net assets |
General funds Designated funds Restricted funds 2025 Total funds 2024 Total funds £ £ £ £ £ - 5,553,950 - 5,553,950 7,043,206 6,366,851 - 125,640 6,492,491 6,389,221 (4,278,944) - - (4,278,944) (3,699,806) - - - - (16,975) |
|---|---|
| 2,087,907 5,553,950 125,640 7,767,497 9,715,646 |
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
87
16. MOVEMENT IN FUNDS
| 16. MOVEMENT IN FUNDS | |||||
|---|---|---|---|---|---|
| Balance at | Incoming | Resources | Transfers | Balance at 30 | |
| 1 October 2024 | resources | expended | between funds | September 2025 | |
| £ | £ | £ | £ | £ | |
| General funds | 2,597,162 | 10,862,700 | (12,879,967) | 1,508,012 | 2,087,907 |
| Total general funds | 2,597,162 | 10,862,700 | (12,879,967) | 1,508,012 | 2,087,907 |
| Restricted funds | |||||
| Brachytherapy study | 1,400 | - | - | - | 1,400 |
| Lung Cancer Study | 2,000 | - | - | - | 2,000 |
| Research Funds | 45,290 | 12,561 | - | - | 57,851 |
| Plus Fund | - | 4,010 | - | - | 4,010 |
| Scanner fund | - | 10,971 | - | - | 10,971 |
| AI software | 500 | - | - | - | 500 |
| Small projects | 5,980 | 7,187 | (4,475) | - | 8,692 |
| Project Vital Scan | 10,372 | 8,353 | - | - | 18,725 |
| PET/CT Chairs | - | 13,266 | - | - | 13,266 |
| Vision Precision 600 Project | - | 18,756 | - | (18,756) | - |
| Patient welfare | 9,736 | 2,570 | (4,081) | - | 8,225 |
| Total Restricted funds | 75,278 | 77,674 | (8,556) | (18,756) | 125,640 |
| Designated funds | |||||
| Designated property & | 6,812,206 | - | - | (1,258,256) | 5,553,950 |
| equipment fund | |||||
| IT and Communications & other | 231,000 | - | - | (231,000) | - |
| Total Designated funds | 7,043,206 | - | - | (1,489,256) | 5,553,950 |
| Total | 9,715,646 | 10,940,374 | (12,888,523) | - | 7,767,497 |
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
88
16. MOVEMENT IN FUNDS (continued)
Designated funds
A designated fund is a ‘ring fencing’ by the trustees of existing unrestricted funds for a particular project or use by the charity.
Designated property & equipment fund
The property & equipment fund represents the net book value of the charity’s fixed assets, including the lease and improvements to the premises on site at Mount Vernon Hospital, together with the scanners and other equipment used by the charity in the course of its day to day operations. The transfer to General Funds represents the decrease in value in tangible fixed assets.
The trustees therefore believe that the amounts set aside as designated funds as shown above are appropriate.
General Research Funds
To fund various projects relating to the diagnosis and treatment of cancer and other life limiting conditions.
Scanner fund
Funds raised towards the purchase of replacement scanners.
AI software
Funds raised for the purchase of AI software.
Patient welfare & Plus Fund
To fund equipment to improve patient welfare. During the year furniture was bought for the new reception area using Patient Welfare Fund resources.
IT, Communications & other fund
This fund represents the funds identified by the trustees as required to meet capital expenditure planned for in 2025/26
Restricted funds
Small Projects Funds
Funds relating to the seasonal affective disorder (SAD) lamps used as part of the Bright Light Therapy Project and funds relating to the Enhanced Patient Lounge Experience.
Project Vital Scan
Brachytherapy
To fund a Brachytherapy pilot study which will enable the PhD study to give an extra scan time point.
Lung cancer study
Fund relating to the i-Stat Alinity blood test device.
PET-CT Chairs and Vision Precision 600 Project
Funds for the purchase of specific items of equipment for clinical use.
Grant funding for a lung cancer study
17. RELATED PARTY TRANSACTIONS
The only transactions with related parties, other than those disclosed in note 7, were for payments totalling £1,200 to a business operated by a trustee, Amy Page. These payments were for the provision of Continuing Professional Development services provided to employees of the charity and not for services provided in the performance of duties as a trustee.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
89
18. COMPARATIVE STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 30TH SEPTEMBER 2024
| Notes INCOME Donations and legacies 3 Income from charitable activities: Clinical services 3 Investment income 3 TOTAL INCOME EXPENDITURE Costs of raising funds: Costs of generating voluntary income 5 Charitable activities 6 TOTAL EXPENDITURE NET (EXPENDITURE)/INCOME TRANSFERS BETWEEN FUNDS NET MOVEMENT IN FUNDS FOR THE YEAR RECONCILIATION OF FUNDS FUNDS BROUGHT FORWARD FUNDS CARRIED FORWARD 15 |
General Fund £ 329,035 8,731,638 329,888 |
Designated Fund £ - - - |
Restricted Fund £ 29,259 - - |
Total 2024 £ 358,294 8,731,638 329,888 |
|---|---|---|---|---|
| 9,390,561 272,411 11,201,862 |
- - - |
29,259 - 4,691 |
9,419,820 272,411 11,206,553 |
|
| 11,474,273 | - | 4,691 | 11,478,964 | |
| (2,083,712) (316,705) |
- 367,967 |
24,568 (51,262) |
(2,059,144) - |
|
| (2,400,417) 4,997,579 |
367,967 6,675,239 |
(26,694) 101,972 |
(2,059,144) 11,774,790 |
|
| 2,597,162 | 7,043,206 | 75,278 | 9,715,646 |
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
90
19. ANALYSIS OF INCOME AND EXPENDITURE
| APPEALS FUND | Notes | 2025 | 2024 | ||
|---|---|---|---|---|---|
| £ | £ | £ | £ | ||
| Income | |||||
| Donations, gifts and funds raised | 221,777 | 166,247 | |||
| Donated Services – Google Ads | 13,778 | 34,903 | |||
| Legacies received | 100,989 | 127,369 | |||
| Income tax recoverable | 21,448 | 18,795 | |||
| Bank interest and bank treasury | 88,824 | 136,002 | |||
| Trusts and Grants | 57,005 | 10,980 | |||
| 503,821 | 494,296 | ||||
| Less: expenditure | |||||
| Fundraisers’ salaries and assistance | 223,351 | 193,376 | |||
| Event costs | 19,060 | 16,700 | |||
| Advertising | 13,778 | 34,903 | |||
| Printing and mailing costs | 22,663 | 19,153 | |||
| General expenses | 7,278 | 8,279 | |||
| 286,130 | 272,411 | ||||
| Surplus - appeals fund | 217,691 | 221,885 | |||
| Add: | |||||
| Defcit – Scanner Centre | 20 | (2,165,840) | (2,281,029) | ||
| (Defcit)/Surplus in year | (1,948,149) | (2,059,144) |
The above analysis is included to provide additional information to assist in the understanding of the financial activities of the charity.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S
91
20. ANALYSIS OF INCOME AND EXPENDITURE
| SCANNER CENTRE | Notes | 2025 | 2024 | ||
|---|---|---|---|---|---|
| £ | £ | £ | £ | ||
| Income | |||||
| Fees from patients and health authorities | 10,291,557 | 8,731,638 | |||
| Royalties receivable | - | 48,874 | |||
| Cyclotron rental income | 144,996 | 145,012 | |||
| 10,436,553 | 8,925,524 | ||||
| Less: expenditure | |||||
| Staff salaries and radiologists' fees | 5,386,835 | 4,822,880 | |||
| Other staffng costs | 5,548 | 37,499 | |||
| Maintenance contracts and scanner repairs | 579,126 | 642,123 | |||
| Repairs and renewals of equipment and building | 444,457 | 446,715 | |||
| Lease charges on equipment | 1,500,742 | 1,433,812 | |||
| Medical and surgical supplies, cryogens and | |||||
| other consumables | 2,118,917 | 1,822,920 | |||
| Rent and rates | 290,000 | 170,004 | |||
| Heat, light and facilities | 479,048 | 319,586 | |||
| Printing, postage, stationery and telephone | 77,707 | 74,000 | |||
| Auditors’ remuneration | 18,500 | 17,000 | |||
| Medical conferences and travel | 12,179 | 10,872 | |||
| Miscellaneous expenses | 58,075 | 9,194 | |||
| Bank charges | 4,460 | 3,762 | |||
| Legal, professional and consultancy fees | 96,696 | 104,904 | |||
| Insurance | 172,238 | 161,584 | |||
| Interest on fnance leases | 1,441 | 2,495 | |||
| Depreciation | 1,356,424 | 1,127,203 | |||
| 12,602,393 | 11,206,553 | ||||
| Defcit - scanner centre | (2,165,840) | (2,281,029) |
The above analysis is included to provide additional information to assist in the understanding of the financial activities of the Charity.
N O T E S T O T H E F I N A N C I A L S T A T E M E N T S